Health Trials

Intracranial Arteriovenous Malformations

2

Review clinical trials related to Intracranial Arteriovenous Malformations. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

PHIL® Embolic System Pediatric IDE

The purpose of this study is to collect information about how the PHIL® Embolic System works in the treatment of intracranial dural arteriovenous fistulas. Data collected in this study will be used to evaluate the safety and probable benefits in treating DAVFs. The PHIL® Embolic System is a Humanitarian Use Device (HUD). The U.S. Food and Drug Administration (FDA) approved the use of the PHIL Embolic System as a HUD in June 2016.

Participants needed: 15
Trial details
Age: Up to 21Biological sex: AllType: InterventionalSponsor: Alejandro BerensteinUpdated: Mar 27, 2026Locations: 1
Eligibility criteria

Subject is <22 years of age [+3]

Subject presents with an intracranial mass or is currently undergoing radiation... [+13]

Read more
Status: Recruiting

Efficacy and Safety of the Liquid Embolic System (Tonbridge) for Endovascular Treatment of Cerebrovascular Malformations

The purpose of this study is to verify the efficacy and safety of the Liquid Embolic System (Tonbridge Medical Tech. Co., Ltd. (Suzhou)) for the treatment of cerebrovascular malformations.

Participants needed: 170
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Ton-Bridge Medical Tech. Co., LtdUpdated: Sep 19, 2024Locations: 14
Eligibility criteria

Age 18 to 80 years, any gender; [+2]

Intracranial hemorrhage within 1 month prior to treatment; [+11]

Read more